drugset / Trial / NCT00791739

Trazodone and Its Augmentation With Pregabalin in the Treatment of Fibromyalgia

NCT00791739

Phase 4 Completed 66 enrolled University of Granada
NaSingle-groupOpen-labelTreatment

Summary

The study has a double purpose: a first phase intends to assess the effectiveness and tolerability of trazodone, an antidepressant with sedative and sleep-promoting properties, in the treatment of fibromyalgia; a second phase intends to evaluate if the addition of pregabalin to patients who have shown a partial response to trazodone additionally improves fibromyalgia symptomatology.

Timeline

Start
2008-04
Primary completion
2009-07
Completion
2009-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Pregabalin Small molecule 75 mg
Subject Trazodone Small molecule 50 mg

Indications